DPP4i), and the primary outcome was all thromboembolic events (cerebral infarction, myocardial infarction [MI], deep vein thrombosis [DVT], pulmonary embolism [PE]) within 5 years after GLP-1 analog or DPP4i start
Weight Management: Keeping a healthy weight reduces the strain on your heart
Reduced Risk of Obesity-Related Diseases Lowers the risk of diabetes, heart disease, and high blood pressure
Your provider may also recommend an abdominal assessment if you have a history of gallbladder issues or pancreatitis, as these are relevant safety considerations for GLP-1 therapy
The sustained elevation of pulmonary arterial pressure increases right ventricular afterload, thereby predisposing individuals to right-sided heart failure [175,176,177]